The combined characteristics of cholesterol metabolism and the immune microenvironment may serve as valuable biomarkers for both the prognosis and treatment of …
W Bai - Heliyon, 2023 - cell.com
Background Hepatocellular carcinoma (HCC) being a complex disease, commonly exhibits
multifaceted presentations, rendering its treatment challenging and necessitating specific …
multifaceted presentations, rendering its treatment challenging and necessitating specific …
Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment
D Athavale, H Yaduvanshi, FK Bhati, SS Mayengbam… - bioRxiv, 2024 - biorxiv.org
Avasimibe; a cholesterol-lowering drug with a proven safety in clinical trials, has recently
been repositioned as an anticancer agent in various preclinical investigations. A study from …
been repositioned as an anticancer agent in various preclinical investigations. A study from …